Halozyme Therapeutics reported $117.15M in Current Liabilities for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 59.83M 1.93M
Aptinyx Inc APTX:US $ 4.74M 949K
Cytokinetics CYTK:US $ 66.85M 5.01M
Immunogen IMGN:US $ 84.12M 16.83M
Intrexon XON:US $ 28.99M 0.12M
IONIS PHARMACEUT IONS:US $ 241M 38.78M
Minerva Neurosciences NERV:US $ 3.25M 0.43M
Nektar Therapeutics NKTR:US $ 85.2M 54.77M
Peregrine Pharmaceuticals PPHM:US $ 69.53M 6.28M